Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Prof. Dr. med. Julia Carolin Stingl
Prof. Dr. med. Julia Carolin Stingl
Vice President of the Federal Institute for Drugs and Medical Devices, Work group leader at the Department of Pharmacology, University of Cologne, Department of General Pharmacology
Professor and Director Research at the Federal Institute for Drugs and Medical Devices
USA
Biography

1991 to 1997 Study of Medicine, Johann Wolfgang Goethe University, Frankfurt a. Main 1991 to 1997 Scholarship according to the Bavarian Gifted Promotion Act (BayBFG) Nov . 1997 State exams in medicine Nov . 1997 Approval as a doctor, dissertation: detection of mutations in the Ki-ras gene in human pancreatic tissue by means of DNA sequence analysis and analysis of single-strand conformational polymorphisms (SSCP) 01.12.1997 - 31.05.1999 Work as a doctor in an internship at the psychiatric clinic at Benjamin Franklin University of the Freie Universität Berlin. Study coordinator for the study of the pharmacogenetically based optimization of therapy with antipsychotics in schizophrenia 01.06.1999 - 31.12.2003 Research associate at the Institute of Clinical Pharmacology, Charité, Humboldt University, Berlin. Head of the Research Group Pharmacogenetic Diagnostics and Therapy Recommendations and Laboratory Director of the Laboratory for Pharmacogenetic Diagnostics at the Institute of Clinical Pharmacology 11.12.2003 Recognition as a specialist in clinical pharmacology 01.01.2004 - 31.12.2004 Research associate at the Institute of Pharmacology, University of Cologne, Department of Clinical Pharmacology. Head of Pharmacogenetics in Clinical Studies 01.03.2004 Appointment as an extraordinary member of the Medical Committee of the German Medical Society 21/06/2004 21.06.2004 Habilitation for the subject of Clinical Pharmacology. Subject of the Habilitationsschrift: Pharmacogenetically based therapy recommendations 01.01.2005 - 31.01.2006 Work group leader at the Department of Pharmacology, University of Cologne, Department of General Pharmacology 01.02.2006 - 30.04.2012 Professor (W3) for Clinical Pharmacology at the Institute for Naturopathology and Clinical Pharmacology, University of Ulm Since 01.05.2012 Professor and Director Research at the Federal Institute for Drugs and Medical Devices ( BfArM ), co-opted by the Medical Faculty of the University of Bonn as a professor of translational pharmacology Since 01.10.2014 Vice President of the Federal Institute for Drugs and Medical Devices Stay abroad USA 01.03.-30.04. 2009 Invited Professorship, Appointment to the Research Participation Program at the Center for Drug Evaluation and Research (CDER), US Food and Drug Administration ( FDA ), Washington, US Publications / Other activities Prof. Dr. Stingl published more than 150 scientific papers and book contributions in the field of individualized drug therapy, drug safety and pharmacogenetics. Prof. Dr. Stingl manages and coordinates numerous third-party international research projects as well as European research groups. These are available under the following link: Publications: Prof. Dr. Stingl is a member of numerous scientific associations and is an associate member of the German Medical Association (AKDAE) and has received several awards (2003: Presidential Trainee Award from the American Society for Clinical Phamacology and Therapeutics, 2009: The Utrecht Award for Excellence in Pharmaceutical Research , 2010: Leon Goldberg Young Investigator Award).

Allied Academies Global Conference Directory

Mail us at

neuropharma@alliedconferences.org
neuropharma@alliedconferences.org
neuropharmaceutics@alliedmeetings.org
neuropharmaceutics@alliedmeetings.org
neuropharmaceuticals@protonmail.com
neuropharmaceuticals@protonmail.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.